PHASE-I CLINICAL-EVALUATION OF ORAL AND INTRAVENOUS 4-DEMETHOXYDAUNORUBICIN

被引：6
|
作者：
KAVANAGH, JJ
YEUNG, KY
SAVARAJ, N
KRAKOFF, IH
机构：
来源：
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1985年 / 21卷 / 10期
关键词：
D O I：
10.1016/0277-5379(85)90013-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1187 / 1189
页数：3
相关论文
共 50 条
  • [31] PHASE-II TRIAL OF 4-DEMETHOXYDAUNORUBICIN (DMDR) FOR ADVANCED HYPERNEPHROMA
    SCHER, HI
    YAGODA, A
    AHMED, T
    BUDMAN, D
    SORDILLO, P
    WATSON, RC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (01) : 79 - 80
  • [32] IDARUBICIN (4-DEMETHOXYDAUNORUBICIN) - A PRELIMINARY OVERVIEW OF PRECLINICAL AND CLINICAL-STUDIES
    GANZINA, F
    PACCIARINI, MA
    DIPIETRO, N
    INVESTIGATIONAL NEW DRUGS, 1986, 4 (01) : 85 - 105
  • [33] PHASE-I EVALUATION OF ORAL TEGAFUR
    BEDIKIAN, AY
    BODEY, GP
    VALDIVIESO, M
    BURGESS, MA
    CANCER TREATMENT REPORTS, 1983, 67 (01): : 81 - 84
  • [34] A PHASE-II TRIAL OF ORAL 4-DEMETHOXYDAUNORUBICIN (DMDR) IN PATIENTS WITH MEASURABLE ADVANCED BREAST-CARCINOMA
    BASTHOLT, L
    EJLERTSEN, B
    DALMARK, M
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 125 - 125
  • [35] A PHASE-II STUDY OF IDARUBICIN (4-DEMETHOXYDAUNORUBICIN) IN ADVANCED MYELOMA
    CHISESI, T
    CAPNIST, G
    DEDOMINICIS, E
    DINI, E
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (04): : 681 - 684
  • [36] PHASE-I CLINICAL-EVALUATION OF HUMAN-PLASMA FIBRONECTIN (FN) IN TRAUMA PATIENTS
    HOROWITZ, MS
    HOROWITZ, B
    MAY, JR
    TREAT, RC
    HALL, EL
    DIPIRO, JT
    DORAN, JE
    MANSBERGER, AR
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 248 - 248
  • [37] A PHASE-I CLINICAL-EVALUATION OF TCNU - A NEW WATER-SOLUBLE NITROSOUREA COMPOUND
    VIBEPETERSEN, J
    HANSEN, HH
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 106 - 106
  • [38] PHASE-I CLINICAL-EVALUATION OF A NEW IRON-OXIDE MR CONTRAST AGENT
    MCLACHLAN, SJ
    MORRIS, MR
    LUCAS, MA
    FISCO, RA
    EAKINS, MN
    FOWLER, DR
    SCHEETZ, RB
    OLUKOTUN, AY
    JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING, 1994, 4 (03): : 301 - 307
  • [39] ACTIVITY AND DISTRIBUTION OF IV AND ORAL 4-DEMETHOXYDAUNORUBICIN IN MURINE EXPERIMENTAL-TUMORS
    BROGGINI, M
    ITALIA, C
    COLOMBO, T
    MARMONTI, L
    DONELLI, MG
    CANCER TREATMENT REPORTS, 1984, 68 (05): : 739 - 747
  • [40] A PHASE-II TRIAL OF ORAL 4-DEMETHOXYDAUNORUBICIN (DMDR) IN PATIENTS WITH MEASURABLE ADVANCED-CARCINOMA OF THE BREAST
    BASTHOLT, L
    EJLERTSEN, B
    DALMARK, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 164 - 164
12345